CANTON, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the ...
Tuckner's remarks came as he explained the economic background behind the credit loss expense, which he said UBS was expecting for the fourth quarter. "The (macro) environment in Switzerland is OK," ...